Application of the COM-B Model of Behavior used to describe barriers to early TB treatment. by Wani Muzeyi (9628527)

Subjects: “…bacteriologically confirmed cases…”

Greenhouse Gas and Air Pollutant Emissions from Composting by Sarah L. Nordahl (9148006)

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

“…<p><b>(A)</b> The crucial period and outcome measurement period in the current study. …”

Map of the Western Ghats depicting the locations of Shivamogga (a KFD endemic district) and Wayanad (emergent district) within India, and reported KFD outbreak cases (2014–2019). by Festus A. Asaaga (10292171)

Loss of ECRG4 results in more severe cutaneous MRSA infections with systemic dissemination of bacteria. by Katie D. Pool (20141584)

Subjects:

First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

Subjects:

Loss of ECRG4 impairs early neutrophil recruitment but not the local cutaneous cytokine response to infection. by Katie D. Pool (20141584)

Subjects:

ECRG4 regulates neutrophil surface expression of adhesion molecules. by Katie D. Pool (20141584)

Subjects:

Gating strategy for flow cytometry. by Katie D. Pool (20141584)

Subjects:

ECRG4 and adhesion molecule expression in diabetic patients. by Katie D. Pool (20141584)

Subjects:

ECRG4 regulates neutrophils migration to chemoattractants. by Katie D. Pool (20141584)

Subjects:

First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

Subjects:

Mercury Can Bond to α‑Carbon of Curcumin Increasing Stability in Aqueous Medium and Demonstrated Selective Cytotoxicity against Acute Leukemia by Sougata Mondal (21174904)

Mercury Can Bond to α‑Carbon of Curcumin Increasing Stability in Aqueous Medium and Demonstrated Selective Cytotoxicity against Acute Leukemia by Sougata Mondal (21174904)

Table_1_Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A pr... by Debaprasad Parai (4890775)

“…This study was performed to investigate the persistence and dynamicity of BBV-152 (Covaxin)- and AZD1222 (Covishield)-induced immunoglobulin-G (IgG) antibodies over the year and neutralizing antibodies’ status after 1-month of booster dose.…”

Table_2_Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A pr... by Debaprasad Parai (4890775)

“…This study was performed to investigate the persistence and dynamicity of BBV-152 (Covaxin)- and AZD1222 (Covishield)-induced immunoglobulin-G (IgG) antibodies over the year and neutralizing antibodies’ status after 1-month of booster dose.…”

Fig 4 - by Rafael Alves Guimarães (4526788)

Fig 3 - by Rafael Alves Guimarães (4526788)

Measures of access and affordability by income level, age 57 to 73 years. by Rahul Aggarwal (4428457)

Percentage of US adults with health insurance coverage by income-level, age 60 to 70 years. by Rahul Aggarwal (4428457)